NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
05/06/2025
Back to search
Official data from USPTO
RETHINKDEPRESSION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
05/07/2025
Trademark type
Combined
Nice classes
5, 41, 42, 44
Filing date
05/25/2017
Registration date
11/13/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/15/2025
Last transaction
05/07/2025
Responsible office
United States Patent and Trademark Office
Status code
704
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
99
Owner location
Valby, DK
Examiner
CARLYLE, SHAUNIA
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the words "RETHINKDEPRESSION" with a thought cloud over the letter "I." The word "RETHINK" is in blue; the word "DEPRESSION" and the thought cloud are in red. The color white is not claimed as a feature of the mark and represents background.
Holders and representatives
Holders
H. Lundbeck A/S
H. Lundbeck A/S
Representatives
Maren C. Perry King & Spalding LLP
Technical classification
Nice Classes
Class 5Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases ingenerated by or acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementiaAlzheimer's disease and disorderdizzinessseizuresstrokedepressioncognitive impairmentcognitive disorders and diseasesmood disorderspsychosisanxietyapathyepilepsyLennox-Gastaut syndrome (LGS)sclerosisporphyriaHuntington's disease and disorderinsomniaParkinson's disease and disorderfallsmovement disorders and diseasesschizophreniabipolar disorder and diseaseADHDoncologypainalcoholism and dependency; medical preparationssubstancesreagents and diagnostic agents for medical purposes
Class 41
Education servicesarranging and conducting seminarsconferencessymposiumsworkshops and courses in the field of medical research and developmentscienceclinical studiestests and trialsdiagnosticmedicinepharmaceuticalsdisordersdiseasestreatment and prevention; educational and training services in the field of research and development relating to the treatment and prevention of central nervous system diseases and disorders; providing the aforementioned services electronicallyon-linevia cable or Internet or other electronic media; arranging and conducting expert forumsincluding on-line in the form of seminarsconferencessymposiumsworkshops and courses in the field of research and development relating to the treatment and prevention of central nervous system diseases and disorders; providing on-line training programs in the field of research and development relating to the treatment and prevention of central nervous system diseases and disorders; providing on-line publicationsbooksreportsbrochuresbookletsleafletspatient information leafletsmagazinesjournalsteaching and educational material in the field of research and development relating to the treatment and prevention of central nervous system diseases and disorders
Class 42
Scientific and technological servicesresearch and design in the field of pharmaceuticals for the treatment and prevention of diseases and disorders of the central nervous system; medical and scientific researchconducting clinical trials for others; clinical studies tests and trials; industrial analysis and research in the field of research and development relating to the treatment and prevention of diseases and disorders of the central nervous system; pharmaceutical research and development services; medical research; providing information in the field of research and development related to the treatment and prevention of central nervous system diseases and disorders
Class 44
Medical and therapeutic services relating to the treatment and prevention of brain and central nervous system diseases and disorders; healthcare servicesclinical healthcare; medicalclinicaltherapeutic clinical services in the field of brain and central nervous system diseases and disorders; healthcare information services; medical services in the field of psychiatry and psychology and medical treatment of central nervous system related diseases and disorders; medical advice related to the treatment of central nervous system diseases and disorders; healthcare and medical services related to the treatment and prevention of central nervous system and brain diseases and disorders; providing medical and medicinal information in the field of diagnosticsmedicine and pharmaceuticals for the treatment and prevention of diseases and disorders of the central nervous system; providing on-line medical informationdata and analyses designed to provide patients and clients with customized information regarding diagnosis and treatment
Publications
History of USPTO decisions and trademark events.
38 publications found
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
04/15/2025
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
04/15/2025
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
04/15/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/07/2025
ES8R
TEAS SECTION 8 RECEIVED
11/08/2024
ES7R
TEAS SECTION 7 REQUEST RECEIVED
11/08/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/22/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/22/2024
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
03/22/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/22/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/22/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/13/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
11/13/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/28/2018
PUBO
PUBLISHED FOR OPPOSITION
08/28/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/08/2018
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
07/23/2018
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
07/20/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/16/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
07/16/2018
ALIE
ASSIGNED TO LIE
07/16/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/16/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
07/16/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/16/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/24/2018
GNRT
NON-FINAL ACTION E-MAILED
01/24/2018
CNRT
NON-FINAL ACTION WRITTEN
01/24/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/03/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/02/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/02/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/10/2017
GNRT
NON-FINAL ACTION E-MAILED
07/10/2017
CNRT
NON-FINAL ACTION WRITTEN
07/10/2017
DOCK
ASSIGNED TO EXAMINER
07/03/2017
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/02/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/01/2017
NWAP
NEW APPLICATION ENTERED
05/29/2017
Continuous trademark protection
Get notified about every new filing that threatens RETHINKDEPRESSION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.